| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $348K | -98.2% | -98.8% |
| R&D Expense | $31.0M | +12.6% | -13.3% |
| SG&A Expense | $24.5M | -10.1% | +33.2% |
| Operating Income | -$55.1M | -54.7% | -120.5% |
| Pre-tax Income | -$72.0M | -314.7% | -332.5% |
| Income Tax | -$1K | — | +0.0% |
| Net Income | -$72.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $538.4M | -4.5% | +27.4% |
| Short-term Investments | $164.5M | -6.1% | — |
| Current Assets | $732.3M | -4.9% | +67.2% |
| Total Assets | $786.4M | -3.5% | +79.1% |
| Current Liabilities | $58.3M | +59.6% | +41.2% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$106.9M | — | — |
| Investing Cash Flow | -$153.8M | — | — |
| Financing Cash Flow | $15.8M | — | — |
| -332.5% |
| EPS (Basic) | -$0.61 | -306.7% | -238.9% |
| EPS (Diluted) | -$0.61 | -306.7% | -238.9% |
| $58.4M |
| +59.4% |
| -3.3% |
| Stockholders' Equity | $728.1M | -6.5% | +92.2% |